Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

189

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
B05CX01	SERUFLEX DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	171,228 L.L
C03DA04	HEPERONA 50	G	Eplerenone - 50mg	50mg	Tablet, coated	2,150,148 L.L
C09CA04	GIZLAN	G	Irbesartan - 150mg	150mg	Tablet, film coated	748,520 L.L
C10AA05	TARDELIP	G	Atorvastatin - 80mg	80mg	Tablet, film coated	1,055,876 L.L
D10AD01	TRETINOIN	G	Tretinoin - 0.05%	0.05%	Solution	623,287 L.L
G04BE08	APO-TADALAFIL	G	Tadalafil - 5mg	5mg	Tablet	1,635,456 L.L
J01CR05	PIPERACILLIN/TAZOBACTAM SANDOZ	G	Piperacillin (sodium) - 4g, Tazobactam (sodium) - 0.5g		Injectable powder for solution	913,813 L.L
J01MA02	SUPERFLOX	G	Ciprofloxacine (HCl) - 500mg	500mg	Tablet, film-scored	458,250 L.L
L02BG04	LEFFTARA	G	Letrozole - 2.5mg	2.5mg	Tablet, film coated	2,060,111 L.L
M01AB15	KETO-AVI	G	Ketorolac tromethamine - 30mg/ml	30mg/ml	Injectable solution	106,164 L.L
N01BB02	LIDOCAINE ARWAN	G	Lidocaine (HCl) - 1%	1%	Injectable solution	1,995,158 L.L
N05BA12	ALPRAZOLAM BIOGARAN	G	Alprazolam - 0.25mg	0.25mg	Tablet, scored	115,570 L.L
R05X	CODOPALM EXPECTORANT	G	Ipeca Tincture - 3mg, Promethazine HCl - 100mg, Potassium guaiacosulfonate - 0.9g		Syrup	153,582 L.L
A02BC01	OMEPRAL	G	Omeprazole - 10mg	10mg	Powder for suspension	890,776 L.L
B05CX01	SERUFLEX DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	193,062 L.L
C03DA05	KERENDIA	G	Finerenone - 10mg	10mg	Tablet, film coated	6,353,687 L.L
C09CA04	IRBAVEL 150	G	Irbesartan - 150mg	150mg	Tablet, film coated	564,414 L.L
D10AD01	TRETINOIN	G	Tretinoin - 0.025%	0.025%	Solution	564,414 L.L
G04BE08	DURALIS 5	G	Tadalafil - 5mg	5mg	Tablet, film coated	1,791,790 L.L
J01CR05	PIPERACILLIN/TAZOBACTAM SANDOZ	G	Piperacillin (sodium) - 4g, Tazobactam (sodium) - 0.5g		Injectable powder for solution	7,961,483 L.L
J01MA02	CIPROFLOXACINE PANPHARMA	G	Ciprofloxacine (HCl) - 200mg/100ml	200mg/100ml	Injectable solution	5,120,040 L.L
L02BG04	LETROZOLE ARROW	G	Letrozole - 2.5mg	2.5mg	Tablet, film coated	2,402,790 L.L
M01AB15	KETOLAC	G	Ketorolac trometamine - 30mg/2ml	30mg/2ml	Injectable solution	106,164 L.L
N01BB02	? 1% LIDOCAINE HCL USP	G	Lidocaine HCl - 1%	1%	Injectable solution	76,791 L.L
N05BA12	ALPROX	G	Alprazolam - 1mg	1mg	Tablet	895,895 L.L
R05X	CODOPALM EXPECTORANT	G	Ipeca Tincture - 3mg, Promethazine HCl - 100mg, Potassium guaiacosulfonate - 0.9g		Syrup	291,806 L.L
V03AC03	DEFERASIROX ARROW	G	Deferasirox - 180mg	180mg	Tablet, coated	9,056,837 L.L
A02BC02	GASTROPAN	G	Pantoprazole (sodium) - 40mg	40mg	Tablet, enteric coated	1,104,639 L.L
B05CX01	SOLUFLEX DEXTROSE 5% INJECTION USP	G	Glucose - 5%	5%	Injectable solution	186,167 L.L
C03DA05	KERENDIA	G	Finerenone - 20mg	20mg	Tablet, film coated	6,353,687 L.L

...

189